Lund Melanoma Study Group
121 – 130 of 258
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Patient Characteristics Influence Activated Signal Transducer and Activator of Transcription 3 (STAT3) Levels in Primary Breast Cancer—Impact on Prognosis
- Contribution to journal › Article
-
Mark
Comment on "factors affecting sentinel node metastasis in thin (T1) cutaneous melanomas : Development and external validation of a predictive nomogram"
- Contribution to journal › Letter
-
Mark
CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
- Contribution to journal › Article
-
Mark
TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant Melanoma
- Contribution to journal › Article
- 2019
-
Mark
Shared heritability and functional enrichment across six solid cancers
- Contribution to journal › Article
-
Mark
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
- Contribution to journal › Article
-
Mark
Circulating insulin-like growth factor I in relation to melanoma risk in the European prospective investigation into cancer and nutrition
- Contribution to journal › Article
-
Mark
Improved survival prognostication of node-positive malignant melanoma patients utilizing shotgun proteomics guided by histopathological characterization and genomic data
- Contribution to journal › Article
-
Mark
Physical activity and survival following breast cancer
- Contribution to journal › Article
-
Mark
Clinical protein science in translational medicine targeting malignant melanoma
- Contribution to journal › Article
